Published in Clin Transl Gastroenterol on February 05, 2015
Glycosylation-Based Serum Biomarkers for Cancer Diagnostics and Prognostics. Biomed Res Int (2015) 0.77
The prognostic value of serum CA 19-9 for patients with advanced lung adenocarcinoma. BMC Cancer (2016) 0.75
Preoperative Carbohydrate Antigen 19-9: Its Neglected Role in Alpha-Fetoprotein-Negative Hepatocellular Carcinoma Patients. J Gastrointest Surg (2017) 0.75
Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med (1996) 22.46
Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005. J Clin Oncol (2009) 9.84
A novel prognostic subtype of human hepatocellular carcinoma derived from hepatic progenitor cells. Nat Med (2006) 6.31
Oligonucleotide microarray for prediction of early intrahepatic recurrence of hepatocellular carcinoma after curative resection. Lancet (2003) 3.93
Primary liver cancer in Japan. Clinicopathologic features and results of surgical treatment. Ann Surg (1990) 3.25
Liver transplantation for hepatocellular carcinoma: impact of the MELD allocation system and predictors of survival. Gastroenterology (2008) 2.59
The clinical utility of serum CA 19-9 in the diagnosis, prognosis and management of pancreatic adenocarcinoma: An evidence based appraisal. J Gastrointest Oncol (2012) 2.38
Liver stem cells and hepatocellular carcinoma. Hepatology (2009) 2.27
Liver transplantation for hepatocellular carcinoma: extension of indications based on molecular markers. J Hepatol (2008) 2.22
Modeling pathogenesis of primary liver cancer in lineage-specific mouse cell types. Gastroenterology (2013) 1.76
Early alpha-fetoprotein response predicts treatment efficacy of antiangiogenic systemic therapy in patients with advanced hepatocellular carcinoma. Cancer (2010) 1.48
CA19-9 serum levels in obstructive jaundice: clinical value in benign and malignant conditions. Am J Surg (2009) 1.31
Accuracy of common hapatic duct size in the evaluation of extrahepatic biliary obstruction. Radiology (1980) 1.30
Systematic review: the prognostic role of alpha-fetoprotein following liver transplantation for hepatocellular carcinoma. Aliment Pharmacol Ther (2012) 1.29
The immunohistochemical phenotype of dysplastic foci in human liver: correlation with putative progenitor cells. J Hepatol (2000) 1.28
A clinicopathological study on combined hepatocellular and cholangiocarcinoma. J Gastroenterol Hepatol (1996) 1.25
Combined hepatocellular and cholangiocarcinoma: proposed criteria according to cytokeratin expression and analysis of clinicopathologic features. Hum Pathol (1995) 1.20
Combined hepatocellular and cholangiocarcinoma: clinical features and prognostic study in a Thai population. J Hepatobiliary Pancreat Surg (2006) 1.09
Surgical treatments and prognoses of patients with combined hepatocellular carcinoma and cholangiocarcinoma. Ann Surg Oncol (2009) 1.05
Combined hepatocellular carcinoma and cholangiocarcinoma: clinical features, treatment modalities, and prognosis. Ann Surg Oncol (2012) 1.05
CA 19-9 in non-neoplastic liver diseases. A clinical and laboratory study. Clin Chim Acta (1992) 1.00
Level of α-fetoprotein predicts mortality among patients with hepatitis C-related hepatocellular carcinoma. Clin Gastroenterol Hepatol (2011) 0.99
Background progenitor activation is associated with recurrence after hepatectomy of combined hepatocellular-cholangiocarcinoma. Hepatology (2012) 0.98
Is serum alpha-fetoprotein useful for predicting recurrence and mortality specific to hepatocellular carcinoma after hepatectomy? A test based on propensity scores and competing risks analysis. Ann Surg Oncol (2012) 0.96
Intermediate hepatobiliary cells predict an increased risk of hepatocarcinogenesis in patients with hepatitis C virus-related cirrhosis. Gastroenterology (2010) 0.89
Smoking and serum CA19-9 levels according to Lewis and secretor genotypes. Int J Cancer (2008) 0.88
Extra-hepatic cholestasis determines a reversible increase of glycoproteic tumour markers in benign and malignant diseases. Eur J Clin Invest (1992) 0.86
Intrahepatic cholangiocarcinoma or mixed hepatocellular-cholangiocarcinoma in patients undergoing liver transplantation: a Spanish matched cohort multicenter study. Ann Surg (2014) 0.84
Impact of tumor factors on the prognosis of patients with advanced cirrhosis (Child-Pugh class C) and hepatocellular carcinoma. J Gastroenterol Hepatol (2005) 0.83
Role of alpha-fetoprotein in selection of patients with hepatocellular carcinoma waiting for liver transplantation: must we reconsider it? Int J Biol Markers (2011) 0.81
Factors influencing the prognosis of patients with intrahepatic cholangiocarcinoma. Acta Gastroenterol Belg (2012) 0.81
Clinical and molecular classification of hepatocellular carcinoma. Liver Transpl (2007) 0.81
Clinical efficacy of non-transplant therapies in patients with hepatocellular carcinoma with Child-Pugh C liver cirrhosis. Anticancer Res (2014) 0.81
Beyond Milan criteria--chances and risks of expanding transplantation criteria for HCC patients with liver cirrhosis. Clin Transplant (2009) 0.81
Elevated preoperative serum CA19-9 levels in patients with hepatocellular carcinoma is associated with poor prognosis after resection. ScientificWorldJournal (2013) 0.80
Serum levels of preoperative α-fetoprotein and CA19-9 predict survival of hepatic carcinoma patients after liver transplantation. Eur J Gastroenterol Hepatol (2014) 0.80
Predictive factors of downstaging of hepatocellular carcinoma beyond the Milan criteria treated with intra-arterial therapies. Cardiovasc Intervent Radiol (2012) 0.80
A 70-year-old woman with 10 years of markedly elevated alpha-fetoprotein measurements. Semin Liver Dis (2010) 0.77
MR imaging features of primary sclerosing cholangitis: patterns of cirrhosis in relationship to clinical severity of disease. Radiology (2003) 0.77
MR characteristics of acute cholangitis. Acta Radiol (2002) 0.76